Related Experiment Video
Updated: Dec 21, 2025

Construction and Implantation of a Microinfusion System for Sustained Delivery of Neuroactive Agents.
Published on: March 17, 2008
Extended Continuous Infusion of Methylene Blue for Refractory Septic Shock
Abhishek Jaiswal1, Manish Kumar1, Elizabeth Silver1
1Department of Cardiology, Hartford Hospital Heart and Vascular Institute, Hartford, Connecticut, USA.
Objective:
Highlight the utility of methylene blue (MTB) infusion for extended period for refractory vasoplegia.
Introduction:
Hypotension refractory to vasopressor therapy in sepsis is associated with high mortality and limited therapeutic options. Dysregulated nitric oxide (NO) pathway seems to be a major driver, and, therefore, MTB, which inhibits inducible NO synthase activity and decreases cyclic guanosine monophosphate (GMP) accumulation by directly competing with NO by binding to soluble guanylyl cyclase, has been explored.
Case Description:
We describe a successful reversal of refractory septic shock with prolonged MTB infusion in a patient supported on multiple vasopressors at the highest clinical doses as well as venovenous extracorporeal membrane oxygenation (VV-ECMO).
Conclusion And Clinical Significance:
Current report suggests a potential role of MTB infusion in refractory vasoplegia even in advanced vasoplegic shock.
How To Cite This Article:
Jaiswal A, Kumar M, Silver E. Extended Continuous Infusion of Methylene Blue for Refractory Septic Shock. Indian J Crit Care Med 2020;24(3):206-207.
More Related Videos
Related Concept Videos
Continuous Renal Replacement Therapy
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

